Another Korean study by Shin et al. identified 35 patients (8%) with pathogenic mutations in the CHEK2, MSH2, and MUTYH genes in BC patients with clinical features of hereditary cancer syndrome [33]. The gene discussed is CHEK2; the disease is Inherited cancer-predisposing syndrome.